Navigation Links
Genetic-Engineered Cows Resist Mad Cow Disease

Scientists from U.S. and Japan have reported in the journal Nature Biotechnology yesterday about the genetic engineering techniques to produce the first //cattle that may be biologically incapable of getting mad cow disease.

They hope the cattle can be the source of herds that can provide dairy products, gelatin and other products free of the brain-destroying disease, also known as bovine spongiform encephalopathy or BSE. The animals, which lack a gene that is crucial to the disease's progression, were not designed for use as food. They were created so that human pharmaceuticals can be made in their blood without the danger that those products might get contaminated with the infectious agent that causes mad cow.

Writing in the journal, the scientists said their cattle were healthy at the age of 20 months, and sperm from the males made normal embryos that were used to impregnate cows, although it is not certain yet that they could breed normally. They added that the cattle lack the nervous system prions, a type of protein, that cause BSE and other related diseases such as scrapie in sheep and Creutzfeldt-Jakob disease, known as CJD, in humans.

Yoshimi Kuroiwa of Kirin Brewery Company in Tokyo, Japan and colleagues made the cattle, known as knockouts because a specific gene has been "knocked" out of them, using a method they call gene targeting. "By knocking out the prion protein gene and producing healthy calves, our team has successfully demonstrated that normal cellular prion protein is not necessary for the normal development and survival of cattle. The cows are now nearly 2 years old and are completely healthy," said James Robl of Hematech, a South Dakota subsidiary of Kirin.

Mr Robl, an expert in cloning technology, said: "We anticipate that prion protein-free cows will be useful models to study prion disease processes in both animals and humans."

Page: 1

Related medicine news :

1. Link between birth weight and Insulin Resistance
2. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
3. Easier Methods Required to Screen Insulin Resistance
4. Easier Methods Required to Screen Insulin Resistance
5. Insulin Resistance Linked To Difference In Gender
6. Hope for Chemo-Resistant Leukemia Patients
7. Adopting Easier Methods To Screen Insulin Resistance
8. Drug Resistance Questioned in Patients With Chronic Sinusitis
9. Understanding Insulin Resistance
10. Understanding Gene Profiles Could Help Cure A Resistant Form Of Leukemia In Kids
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:

(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology: